Academic Emergency Medicine, ISSN 1069-6563, 05/2005, Volume 12, Issue 5, pp. 431 - 438
Objectives: The authors analyzed contemporary use of glycoprotein (GP) IIb/IIIa inhibitors in patients with non–ST‐segment elevation acute coronary syndrome...
glycoprotein IIb/IIIa inhibitors | non–ST‐segment elevation acute coronary syndrome | guidelines‐recommended therapies | Glycoprotein IIb/IIIa inhibitors | Guidelines-recommended therapies | Non-ST-segment elevation acute coronary syndrome | EMERGENCY | ACC/AHA GUIDELINES | METAANALYSIS | MANAGEMENT | WAVE MYOCARDIAL-INFARCTION | RISK | RECEPTOR | NATIONAL REGISTRY | TRIAL | acute coronary syndrome | non-ST-segment elevation | EMERGENCY MEDICINE | guidelines-recommended therapies | UNSTABLE ANGINA | Biomarkers - metabolism | Acute Disease | Age Factors | Heart Diseases - metabolism | United States | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Patient Selection | Heart Diseases - diagnosis | Practice Patterns, Physicians' - statistics & numerical data | Outcome and Process Assessment (Health Care) | Chest Pain - etiology | Cardiology - statistics & numerical data | Heart Diseases - complications | Sex Factors | Survival Analysis | Electrocardiography | Platelet Glycoprotein GPIIb-IIIa Complex - therapeutic use | Female | Aged | Heart Diseases - drug therapy
glycoprotein IIb/IIIa inhibitors | non–ST‐segment elevation acute coronary syndrome | guidelines‐recommended therapies | Glycoprotein IIb/IIIa inhibitors | Guidelines-recommended therapies | Non-ST-segment elevation acute coronary syndrome | EMERGENCY | ACC/AHA GUIDELINES | METAANALYSIS | MANAGEMENT | WAVE MYOCARDIAL-INFARCTION | RISK | RECEPTOR | NATIONAL REGISTRY | TRIAL | acute coronary syndrome | non-ST-segment elevation | EMERGENCY MEDICINE | guidelines-recommended therapies | UNSTABLE ANGINA | Biomarkers - metabolism | Acute Disease | Age Factors | Heart Diseases - metabolism | United States | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Patient Selection | Heart Diseases - diagnosis | Practice Patterns, Physicians' - statistics & numerical data | Outcome and Process Assessment (Health Care) | Chest Pain - etiology | Cardiology - statistics & numerical data | Heart Diseases - complications | Sex Factors | Survival Analysis | Electrocardiography | Platelet Glycoprotein GPIIb-IIIa Complex - therapeutic use | Female | Aged | Heart Diseases - drug therapy
Journal Article
Academic Emergency Medicine, ISSN 1069-6563, 05/2005, Volume 12, Issue 5, pp. 431 - 438
Objectives: The authors analyzed contemporary use of glycoprotein (GP) IIb/IIIa inhibitors in patients with non-ST-segment elevation acute coronary syndrome...
glycoprotein IIb/IIIa inhibitors | guidelines-recommended therapies | non-ST-segment elevation acute coronary syndrome
glycoprotein IIb/IIIa inhibitors | guidelines-recommended therapies | non-ST-segment elevation acute coronary syndrome
Journal Article
Kardiologia Polska, ISSN 0022-9032, 2007, Volume 65, Issue 8, pp. 861 - 872
Background: in Poland, together with the transformation of the political system, significant positive changes have been made to the national health care...
Guidelines' recommended treatment | In-hospital outcomes | Invasive strategy | Registry | Acute coronary syndromes | Epidemiology | registry | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | CARDIOLOGY | GLOBAL REGISTRY | in-hospital outcomes | GUIDELINES | EUROPEAN-SOCIETY | acute coronary syndromes | epidemiology | TASK-FORCE | ACUTE MYOCARDIAL-INFARCTION | guidelines' recommended treatment | UNSTABLE ANGINA | ST-SEGMENT ELEVATION | EVENTS GRACE | invasive strategy | Myocardial Infarction - diagnosis | Myocardial Infarction - mortality | Hospital Mortality | Heart Conduction System | Humans | Middle Aged | Angina, Unstable - mortality | Acute Coronary Syndrome - mortality | Angina, Unstable - diagnosis | Male | Poland - epidemiology | Angioplasty, Balloon, Coronary | Coronary Angiography | Myocardial Infarction - therapy | Guideline Adherence | Thrombolytic Therapy | Acute Coronary Syndrome - diagnosis | Angina, Unstable - therapy | Electrocardiography | Acute Coronary Syndrome - therapy | Female | Registries | Aged
Guidelines' recommended treatment | In-hospital outcomes | Invasive strategy | Registry | Acute coronary syndromes | Epidemiology | registry | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | CARDIOLOGY | GLOBAL REGISTRY | in-hospital outcomes | GUIDELINES | EUROPEAN-SOCIETY | acute coronary syndromes | epidemiology | TASK-FORCE | ACUTE MYOCARDIAL-INFARCTION | guidelines' recommended treatment | UNSTABLE ANGINA | ST-SEGMENT ELEVATION | EVENTS GRACE | invasive strategy | Myocardial Infarction - diagnosis | Myocardial Infarction - mortality | Hospital Mortality | Heart Conduction System | Humans | Middle Aged | Angina, Unstable - mortality | Acute Coronary Syndrome - mortality | Angina, Unstable - diagnosis | Male | Poland - epidemiology | Angioplasty, Balloon, Coronary | Coronary Angiography | Myocardial Infarction - therapy | Guideline Adherence | Thrombolytic Therapy | Acute Coronary Syndrome - diagnosis | Angina, Unstable - therapy | Electrocardiography | Acute Coronary Syndrome - therapy | Female | Registries | Aged
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 02/2010, Volume 11, Issue 3, pp. 463 - 479
Importance of the field: Asthma is a chronic disease characterized by airway inflammation and hyper-responsiveness. Inhaled corticosteroids (ICSs) constitute...
delivery | systemic effects | ciclesonide | pharmacodynamics | safety | pharmacokinetics | asthma | quality of life | efficacy | inhaled corticosteroids | Pharmacodynamics | Systemic effects | Efficacy | Inhaled corticosteroids | Delivery | Safety | Ciclesonide | Pharmacokinetics | Asthma | Quality of life | ONCE-DAILY CICLESONIDE | OROPHARYNGEAL DEPOSITION | MODERATE PERSISTENT ASTHMA | ADRENAL AXIS FUNCTION | HIGH LUNG DEPOSITION | DAILY INHALED CICLESONIDE | BECLOMETHASONE DIPROPIONATE | FLUTICASONE PROPIONATE | CORTICOSTEROID CICLESONIDE | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | Bronchodilator Agents - therapeutic use | Severity of Illness Index | Hypothalamo-Hypophyseal System - drug effects | Drug Administration Schedule | Pituitary-Adrenal System - drug effects | Anti-Asthmatic Agents - therapeutic use | Humans | Administration, Inhalation | Treatment Outcome | Clinical Trials as Topic | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Pregnenediones - therapeutic use | Randomized Controlled Trials as Topic | Anti-Allergic Agents - therapeutic use | Lung - drug effects | Anti-Asthmatic Agents - administration & dosage | Pharyngeal Diseases | Practice Guidelines as Topic
delivery | systemic effects | ciclesonide | pharmacodynamics | safety | pharmacokinetics | asthma | quality of life | efficacy | inhaled corticosteroids | Pharmacodynamics | Systemic effects | Efficacy | Inhaled corticosteroids | Delivery | Safety | Ciclesonide | Pharmacokinetics | Asthma | Quality of life | ONCE-DAILY CICLESONIDE | OROPHARYNGEAL DEPOSITION | MODERATE PERSISTENT ASTHMA | ADRENAL AXIS FUNCTION | HIGH LUNG DEPOSITION | DAILY INHALED CICLESONIDE | BECLOMETHASONE DIPROPIONATE | FLUTICASONE PROPIONATE | CORTICOSTEROID CICLESONIDE | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | Bronchodilator Agents - therapeutic use | Severity of Illness Index | Hypothalamo-Hypophyseal System - drug effects | Drug Administration Schedule | Pituitary-Adrenal System - drug effects | Anti-Asthmatic Agents - therapeutic use | Humans | Administration, Inhalation | Treatment Outcome | Clinical Trials as Topic | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Pregnenediones - therapeutic use | Randomized Controlled Trials as Topic | Anti-Allergic Agents - therapeutic use | Lung - drug effects | Anti-Asthmatic Agents - administration & dosage | Pharyngeal Diseases | Practice Guidelines as Topic
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 48, Issue 6, pp. 805 - 812
Abstract Purpose To examine five- and ten-year survival based on cancer-specific geriatric assessment (C-SGA) in older women with early stage breast cancer....
Hematology, Oncology and Palliative Medicine | Decision-making | Cancer-specific geriatric assessment | Older women | Geriatric assessment | Guideline-recommended therapy | Survivor | Assessment | Breast cancer | Survival | METAANALYSIS | PATTERNS | CONTROLLED-TRIALS | THERAPY | ONCOLOGY | CLINICAL JUDGMENT | FRAMEWORK | PATIENT | PHYSICIANS REASONS | AGE | Predictive Value of Tests | Humans | Survival Analysis | Aged, 80 and over | Breast Neoplasms - mortality | Female | Geriatric Assessment - methods | Aged | Longitudinal Studies | Cause of Death | Women | Middle aged women | Medical screening | Medicine, Preventive | Preventive health services | decision-making | guideline-recommended therapy | survival | breast cancer | geriatric assessment | cancer-specific geriatric assessment | older women | survivor
Hematology, Oncology and Palliative Medicine | Decision-making | Cancer-specific geriatric assessment | Older women | Geriatric assessment | Guideline-recommended therapy | Survivor | Assessment | Breast cancer | Survival | METAANALYSIS | PATTERNS | CONTROLLED-TRIALS | THERAPY | ONCOLOGY | CLINICAL JUDGMENT | FRAMEWORK | PATIENT | PHYSICIANS REASONS | AGE | Predictive Value of Tests | Humans | Survival Analysis | Aged, 80 and over | Breast Neoplasms - mortality | Female | Geriatric Assessment - methods | Aged | Longitudinal Studies | Cause of Death | Women | Middle aged women | Medical screening | Medicine, Preventive | Preventive health services | decision-making | guideline-recommended therapy | survival | breast cancer | geriatric assessment | cancer-specific geriatric assessment | older women | survivor
Journal Article
03/2011, ISBN 140519555X, 20
This chapter contains sections titled: Introduction Defining a need for the creation or updating of guidelines The multidimensional process of guideline...
Guidelines and Consensus on GI bleeding | stakeholder involvement | areas of future research | CPGs and editorial independence | CPG guideline, recommended methods | identifying and grading evidence | CPG | Vienna Consensus Conference, and GRADE | need for guidelines | Stakeholder involvement | Areas of future research | Guidelines and consensus on GI bleeding | Identifying and grading evidence | Vienna consensus conference, and GRADE | Need for guidelines
Guidelines and Consensus on GI bleeding | stakeholder involvement | areas of future research | CPGs and editorial independence | CPG guideline, recommended methods | identifying and grading evidence | CPG | Vienna Consensus Conference, and GRADE | need for guidelines | Stakeholder involvement | Areas of future research | Guidelines and consensus on GI bleeding | Identifying and grading evidence | Vienna consensus conference, and GRADE | Need for guidelines
Book Chapter
International Journal of Tuberculosis and Lung Disease, ISSN 1027-3719, 12/2011, Volume 15, Issue 12, pp. 1574 - 1586
International surveys have demonstrated that asthma is still underdiagnosed and undertreated in many parts of the world. Despite improvements in the standard...
Asthma management programmes | Asthma education and training | Inhaled corticosteroids | Guideline-recommended treatment | SOUTH-AFRICA | INFECTIOUS DISEASES | REALITY | EVIDENCE-BASED IMPLEMENTATION | asthma education and training | CHILDHOOD ASTHMA | PEDIATRIC ASTHMA | PRIMARY-CARE | guideline-recommended treatment | RESPIRATORY SYSTEM | asthma management programmes | UNCONTROLLED ASTHMA | MULTICENTER SURVEY | LATIN-AMERICA | inhaled corticosteroids | INSIGHTS | Program Development | Global Health | Health Surveys | Humans | Asthma - therapy | International Cooperation | National Health Programs | Practice Guidelines as Topic
Asthma management programmes | Asthma education and training | Inhaled corticosteroids | Guideline-recommended treatment | SOUTH-AFRICA | INFECTIOUS DISEASES | REALITY | EVIDENCE-BASED IMPLEMENTATION | asthma education and training | CHILDHOOD ASTHMA | PEDIATRIC ASTHMA | PRIMARY-CARE | guideline-recommended treatment | RESPIRATORY SYSTEM | asthma management programmes | UNCONTROLLED ASTHMA | MULTICENTER SURVEY | LATIN-AMERICA | inhaled corticosteroids | INSIGHTS | Program Development | Global Health | Health Surveys | Humans | Asthma - therapy | International Cooperation | National Health Programs | Practice Guidelines as Topic
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2012, Volume 28, Issue 4, pp. 443 - 449
Abstract Background The prognostic impact of atrial fibrillation (AF) in the setting of acute coronary syndrome (ACS) is controversial. Furthermore, there are...
Cardiovascular | HOSPITAL MORTALITY | GUIDELINE-RECOMMENDED TREATMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | GRACE RISK SCORE | CANADIAN PERSPECTIVE | PLATELET GLYCOPROTEIN IIB/IIIA | GLOBAL REGISTRY | ACUTE MYOCARDIAL-INFARCTION | PROGNOSTIC-SIGNIFICANCE | ST-SEGMENT ELEVATION | BASE-LINE CHARACTERISTICS | Recurrence | Myocardial Infarction - mortality | Prognosis | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Myocardial Infarction - therapy | Atrial Fibrillation - mortality | Aged, 80 and over | Female | Registries | Atrial Fibrillation - diagnosis | Odds Ratio | Myocardial Infarction - diagnosis | Hospital Mortality | Atrial Fibrillation - therapy | Risk Factors | Stroke Volume - physiology | Combined Modality Therapy | Canada | Coronary Angiography | Outcome and Process Assessment (Health Care) | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Aged
Cardiovascular | HOSPITAL MORTALITY | GUIDELINE-RECOMMENDED TREATMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | GRACE RISK SCORE | CANADIAN PERSPECTIVE | PLATELET GLYCOPROTEIN IIB/IIIA | GLOBAL REGISTRY | ACUTE MYOCARDIAL-INFARCTION | PROGNOSTIC-SIGNIFICANCE | ST-SEGMENT ELEVATION | BASE-LINE CHARACTERISTICS | Recurrence | Myocardial Infarction - mortality | Prognosis | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Myocardial Infarction - therapy | Atrial Fibrillation - mortality | Aged, 80 and over | Female | Registries | Atrial Fibrillation - diagnosis | Odds Ratio | Myocardial Infarction - diagnosis | Hospital Mortality | Atrial Fibrillation - therapy | Risk Factors | Stroke Volume - physiology | Combined Modality Therapy | Canada | Coronary Angiography | Outcome and Process Assessment (Health Care) | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Aged
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 02/2012, Volume 1, Issue 1, pp. 16 - n/a
Background Several therapies are guideline‐recommended to reduce mortality in patients with heart failure (HF) and reduced left ventricular ejection fraction,...
heart failure | nested case‐control studies | survival benefit | guideline‐recommended therapies | TRIALS | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | guideline-recommended therapies | CONVERTING-ENZYME-INHIBITORS | CARE | nested case-control studies | OLDER PATIENTS | CLINICAL EFFECTIVENESS | OUTCOMES | PERFORMANCE-MEASURES
heart failure | nested case‐control studies | survival benefit | guideline‐recommended therapies | TRIALS | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | guideline-recommended therapies | CONVERTING-ENZYME-INHIBITORS | CARE | nested case-control studies | OLDER PATIENTS | CLINICAL EFFECTIVENESS | OUTCOMES | PERFORMANCE-MEASURES
Journal Article
9/2013, Volume 2, Issue 5
Breast cancer is the leading cause of cancer among women in the United States, costing the healthcare system, employers, and society billions of dollars each...
disparities | guideline-recommended treatment | adherence | decision making | Breast cancer | Review | low-wage employment | working poor
disparities | guideline-recommended treatment | adherence | decision making | Breast cancer | Review | low-wage employment | working poor
Book Review
International Journal of Clinical Practice, ISSN 1368-5031, 07/2014, Volume 68, Issue 7, pp. 900 - 918
Summary Objective To estimate the relative efficacy of pharmacological therapies for the treatment of postherpetic neuralgia (PHN), multiple sclerosis...
TOPICAL CAPSAICIN | RANDOMIZED CONTROLLED-TRIALS | MEDICINE, GENERAL & INTERNAL | ISPOR TASK-FORCE | CONCENTRATION CAPSAICIN PATCH | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | GABAPENTIN EXTENDED-RELEASE | LIDOCAINE MEDICATED PLASTER | CENTRAL POSTSTROKE PAIN | HIV-INFECTED PATIENTS | Neuralgia - complications | Humans | Wounds and Injuries - complications | Stroke - complications | Treatment Outcome | Neuralgia, Postherpetic - drug therapy | Stroke - drug therapy | Neuralgia - drug therapy | Multiple Sclerosis - complications | Neuralgia, Postherpetic - complications | Pain - drug therapy | Wounds and Injuries - drug therapy | Multiple Sclerosis - drug therapy | Drug therapy | Human immunodeficiency virus--HIV | Pain management
TOPICAL CAPSAICIN | RANDOMIZED CONTROLLED-TRIALS | MEDICINE, GENERAL & INTERNAL | ISPOR TASK-FORCE | CONCENTRATION CAPSAICIN PATCH | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | GABAPENTIN EXTENDED-RELEASE | LIDOCAINE MEDICATED PLASTER | CENTRAL POSTSTROKE PAIN | HIV-INFECTED PATIENTS | Neuralgia - complications | Humans | Wounds and Injuries - complications | Stroke - complications | Treatment Outcome | Neuralgia, Postherpetic - drug therapy | Stroke - drug therapy | Neuralgia - drug therapy | Multiple Sclerosis - complications | Neuralgia, Postherpetic - complications | Pain - drug therapy | Wounds and Injuries - drug therapy | Multiple Sclerosis - drug therapy | Drug therapy | Human immunodeficiency virus--HIV | Pain management
Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 2015, Volume 29, pp. 52 - 58
Abstract Background: Guidelines on suggested pharmacological treatments for heart failure (HF) are not optimally implemented in clinical practice and whether...
Internal Medicine | Heart failure | Guideline | Hospitalization | Drug therapy | HF Heart failure | HR Hazard ratio | LVSD Left ventricular systolic dysfunction | PLVEF Preserved left ventricular ejection fraction | LVEF Left ventricular ejection fraction | ARB Angiotensin receptor blocker | NT-proBNP N-terminal pro-peptide of brain natriuretic peptide | CI Confidence interval | Abbreviations ACEI Angiotensin-converting enzyme inhibitor | EGFR Bstimated glomerular filtration rate | MDRD Modification of Diet in Renal Disease | MRA Mineralocorticoid receptor antagonist | BB Beta-blocker | NYHA New York Heart Association | GAI Guideline-adherence index | DIAGNOSIS | QUALITY-OF-CARE | GUIDELINE-RECOMMENDED MEDICATIONS | EUROPEAN-SOCIETY | ADHERENCE | MEDICINE, GENERAL & INTERNAL | EUROBSERVATIONAL RESEARCH-PROGRAM | REASONS | ESC-HF PILOT | ASSOCIATION | AGE | Echocardiography | Prospective Studies | Ventricular Function, Left | Humans | Patient Discharge | Male | Treatment Outcome | Drug Prescriptions | Ventricular Dysfunction, Left - physiopathology | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Regression Analysis | Guideline Adherence | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aged, 80 and over | Female | Aged | Heart Failure - diagnostic imaging | Slovenia | Chronic Disease | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Cardiac patients | Angiotensin
Internal Medicine | Heart failure | Guideline | Hospitalization | Drug therapy | HF Heart failure | HR Hazard ratio | LVSD Left ventricular systolic dysfunction | PLVEF Preserved left ventricular ejection fraction | LVEF Left ventricular ejection fraction | ARB Angiotensin receptor blocker | NT-proBNP N-terminal pro-peptide of brain natriuretic peptide | CI Confidence interval | Abbreviations ACEI Angiotensin-converting enzyme inhibitor | EGFR Bstimated glomerular filtration rate | MDRD Modification of Diet in Renal Disease | MRA Mineralocorticoid receptor antagonist | BB Beta-blocker | NYHA New York Heart Association | GAI Guideline-adherence index | DIAGNOSIS | QUALITY-OF-CARE | GUIDELINE-RECOMMENDED MEDICATIONS | EUROPEAN-SOCIETY | ADHERENCE | MEDICINE, GENERAL & INTERNAL | EUROBSERVATIONAL RESEARCH-PROGRAM | REASONS | ESC-HF PILOT | ASSOCIATION | AGE | Echocardiography | Prospective Studies | Ventricular Function, Left | Humans | Patient Discharge | Male | Treatment Outcome | Drug Prescriptions | Ventricular Dysfunction, Left - physiopathology | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Regression Analysis | Guideline Adherence | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aged, 80 and over | Female | Aged | Heart Failure - diagnostic imaging | Slovenia | Chronic Disease | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Cardiac patients | Angiotensin
Journal Article
BMC Cancer, ISSN 1471-2407, 11/2015, Volume 15, Issue 1, p. 937
Background: Ovarian cancer is the fourth most common cancer among women in France, and mainly affects the elderly. The primary objective of this study was to...
Guidelines-recommended therapy | Treatment pattern | Elderly | Survival | Ovarian cancer | MORTALITY | DIAGNOSIS | PROGNOSIS | OLDER | PATTERNS | NET SURVIVAL | CHEMOTHERAPY | WOMEN | ONCOLOGY | CARCINOMA | AGE | Age Factors | Humans | Middle Aged | Ovarian Neoplasms - pathology | Logistic Models | Surgical Procedures, Operative - statistics & numerical data | Regression Analysis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Ovarian Neoplasms - therapy | Female | Aged | France | Combined Modality Therapy - statistics & numerical data | Care and treatment | Cancer patients | Chemotherapy | Oncology, Experimental | Aged patients | Research | Comparative analysis | Cancer | Life Sciences
Guidelines-recommended therapy | Treatment pattern | Elderly | Survival | Ovarian cancer | MORTALITY | DIAGNOSIS | PROGNOSIS | OLDER | PATTERNS | NET SURVIVAL | CHEMOTHERAPY | WOMEN | ONCOLOGY | CARCINOMA | AGE | Age Factors | Humans | Middle Aged | Ovarian Neoplasms - pathology | Logistic Models | Surgical Procedures, Operative - statistics & numerical data | Regression Analysis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Ovarian Neoplasms - therapy | Female | Aged | France | Combined Modality Therapy - statistics & numerical data | Care and treatment | Cancer patients | Chemotherapy | Oncology, Experimental | Aged patients | Research | Comparative analysis | Cancer | Life Sciences
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 07/2015, Volume 24, Issue 7, pp. 722 - 730
Purpose Guideline‐recommended therapy has been proven beneficial in heart failure (HF), but general implementation remains poor. The aim of this study was to...
quality of medical care | heart failure | guideline‐recommended therapy | drug adherence | pharmacoepidemiology | Heart failure | Pharmacoepidemiology | Guideline-recommended therapy | Quality of medical care | Drug adherence | MORTALITY | guideline-recommended therapy | GUIDELINES | IMPROVE HF | EUROPEAN-SOCIETY | HOSPITALIZATION | DELIVERY | READMISSION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PHARMACOLOGY & PHARMACY | THERAPIES | ELDERLY-PATIENTS | HOME-BASED INTERVENTION | Primary Health Care - methods | Primary Health Care - statistics & numerical data | Humans | Kaplan-Meier Estimate | Proportional Hazards Models | Hospitalization - statistics & numerical data | Male | Treatment Outcome | Patient Compliance - statistics & numerical data | Heart Failure - therapy | Austria | Drug Prescriptions - statistics & numerical data | Female | Aged | Drug Therapy - statistics & numerical data | Heart Failure - epidemiology | Heart Failure - mortality | Practice Guidelines as Topic | Enzymes | Enzyme inhibitors | Drug therapy | Analysis | Angiotensin | Compliance | Primary care | Clinical outcomes
quality of medical care | heart failure | guideline‐recommended therapy | drug adherence | pharmacoepidemiology | Heart failure | Pharmacoepidemiology | Guideline-recommended therapy | Quality of medical care | Drug adherence | MORTALITY | guideline-recommended therapy | GUIDELINES | IMPROVE HF | EUROPEAN-SOCIETY | HOSPITALIZATION | DELIVERY | READMISSION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PHARMACOLOGY & PHARMACY | THERAPIES | ELDERLY-PATIENTS | HOME-BASED INTERVENTION | Primary Health Care - methods | Primary Health Care - statistics & numerical data | Humans | Kaplan-Meier Estimate | Proportional Hazards Models | Hospitalization - statistics & numerical data | Male | Treatment Outcome | Patient Compliance - statistics & numerical data | Heart Failure - therapy | Austria | Drug Prescriptions - statistics & numerical data | Female | Aged | Drug Therapy - statistics & numerical data | Heart Failure - epidemiology | Heart Failure - mortality | Practice Guidelines as Topic | Enzymes | Enzyme inhibitors | Drug therapy | Analysis | Angiotensin | Compliance | Primary care | Clinical outcomes
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 03/2016, Volume 18, Issue 3, pp. 298 - 305
Background Increased body mass index (BMI) is a risk factor for heart failure, but evidence regarding BMI in acute heart failure (AHF) remains inconclusive. We...
Heart failure | Body mass index | Guideline‐recommended therapies | Hospitalization | Prognosis | Mortality | Guideline-recommended therapies | SURVIVAL | CACHEXIA | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | OBESITY PARADOX | RISK | Body Mass Index | Acute Disease | Hospital Mortality | Comorbidity | Humans | Middle Aged | Risk Factors | Male | Heart Failure - therapy | Overweight - epidemiology | Aged, 80 and over | Female | Aged | Heart Failure - diagnosis | Retrospective Studies | Heart Failure - epidemiology | Heart Failure - mortality
Heart failure | Body mass index | Guideline‐recommended therapies | Hospitalization | Prognosis | Mortality | Guideline-recommended therapies | SURVIVAL | CACHEXIA | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | OBESITY PARADOX | RISK | Body Mass Index | Acute Disease | Hospital Mortality | Comorbidity | Humans | Middle Aged | Risk Factors | Male | Heart Failure - therapy | Overweight - epidemiology | Aged, 80 and over | Female | Aged | Heart Failure - diagnosis | Retrospective Studies | Heart Failure - epidemiology | Heart Failure - mortality
Journal Article